Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease

NeuroImage: Clinical

Volumn 7, Issue , 2015, Pages 105-113

  Kerbler, Georg M ^a   Fripp, Jürgen ^b   Rowe, Christopher C ^c   Villemagne, Victor L ^c,d   Salvado, Olivier ^b   Rose, Stephen ^b   Coulson, Elizabeth J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b CSIRO   (Australia)

^c AUSTIN HEALTH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alzheimer's disease; Amyloid; Basal forebrain; Magnetic resonance imaging; PET

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; PITTSBURGH COMPOUND B;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLUSTER ANALYSIS; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGONAL BAND OF BROCA; FEMALE; FOREBRAIN; GRAY MATTER; HUMAN; IMAGE PROCESSING; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEYNERT BASAL NUCLEUS; MILD COGNITIVE IMPAIRMENT; NEOCORTEX; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; ATROPHY; COMPUTER ASSISTED DIAGNOSIS; DISEASE COURSE; PATHOLOGY; SCINTISCANNING;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ATROPHY; BASAL FOREBRAIN; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION TOMOGRAPHY;

EID: 84918568695     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2014.11.015     Document Type: Article

References (40)

1. Avants B.B., Yushkevich P., Pluta J., Minkoff D., Korczykowski M., Detre J., and Gee J.C. The optimal template effect in hippocampus studies of diseased populations Neuroimage 49 3 2010 2457 2466 10.1016/j.neuroimage.2009.09.062 19818860
2. Bourgeat P., Chételat G., Villemagne V.L., Fripp J., Raniga P., Pike K., Acosta O., Szoeke C., Ourselin S., Ames D., Ellis K.A., Martins R.N., Masters C.L., Rowe C.C., and Salvado O. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia Neurology 74 2 2010 121 127 10.1212/WNL.0b013e3181c918b5 20065247
3. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., and Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry Acta Neuropathol. 112 4 2006 389 404 10.1007/s00401-006-0127-z 16906426
4. Braak H., and Braak E. Neuropathological staging of Alzheimer-related changes Acta Neuropathol. 82 4 1991 239 259 10.1007/BF00308809 1759558
5. Braak H., and Del Tredici K. Alzheimer's disease: intraneuronal alterations precede insoluble amyloid-beta formation Neurobiol. Aging 25 6 2004 713 718 10.1016/j.neurobiolaging.2003.12.015 15165692 [Discussion 743-716]
6. Braak H., and Del Tredici K. The pathological process underlying Alzheimer's disease in individuals under thirty Acta Neuropathol. 121 2 2011 171 181 10.1007/s00401-010-0789-4 21170538
7. Chételat G., Villemagne V.L., Bourgeat P., Pike K.E., Jones G., Ames D., Ellis K.A., Szoeke C., Martins R.N., O'Keefe G.J., Salvado O., Masters C.L., and Rowe C.C. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease Ann. Neurol. 67 3 2010 317 324 10.1002/ana.21955 20373343
8. Contestabile A. The history of the cholinergic hypothesis Behav. Brain Res. 221 2 2011 334 340 10.1016/j.bbr.2009.12.044 20060018
9. Eickhoff S.B., Heim S., Zilles K., and Amunts K. Testing anatomically specified hypotheses in functional imaging using cytoarchitectonic maps Neuroimage 32 2 2006 570 582 10.1016/j.neuroimage.2006.04.204 16781166
10. Eickhoff S.B., Paus T., Caspers S., Grosbras M.H., Evans A.C., Zilles K., and Amunts K. Assignment of functional activations to probabilistic cytoarchitectonic areas revisited Neuroimage 36 3 2007 511 521 10.1016/j.neuroimage.2007.03.060 17499520
11. Eickhoff S.B., Stephan K.E., Mohlberg H., Grefkes C., Fink G.R., Amunts K., and Zilles K. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data Neuroimage 25 4 2005 1325 1335 10.1016/j.neuroimage.2004.12.034 15850749
12. Ellis K.A., Bush A.I., Darby D., De Fazio D., Foster J., Hudson P., Lautenschlager N.T., Lenzo N., Martins R.N., Maruff P., Masters C., Milner A., Pike K., Rowe C., Savage G., Szoeke C., Taddei K., Villemagne V., Woodward M., and Ames D. The Australian imaging, biomarkers and lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease Int. Psychogeriatr. 21 4 2009 672 687 10.1017/S1041610209009405 19470201
13. Frisoni G.B., Fox N.C., Jack C.R. Jr., Scheltens P., and Thompson P.M. The clinical use of structural MRI in Alzheimer disease Nat. Rev. Neurol. 6 2 2010 67 77 10.1038/nrneurol.2009.215 20139996
14. Garibotto V., Tettamanti M., Marcone A., Florea I., Panzacchi A., Moresco R., Virta J.R., Rinne J., Cappa S.F., and Perani D. Cholinergic activity correlates with reserve proxies in Alzheimer's disease Neurobiol. Aging 34 11 2013 10.1016/j.neurobiolaging.2013.05.020 23820589
15. George S., Mufson E.J., Leurgans S., Shah R.C., Ferrari C., and deToledo-Morrell L. MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD Neurobiol. Aging 32 10 2011 1756 1764 10.1016/j.neurobiolaging.2009.11.006 20005600
16. Gil-Bea F.J., Gerenu G., Aisa B., Kirazov L.P., Schliebs R., and Ramírez M.J. Cholinergic denervation exacerbates amyloid pathology and induces hippocampal atrophy in Tg2576 mice Neurobiol. Disease 48 3 2012 439 446 10.1016/j.nbd.2012.06.020 22759926
17. Greiner M. Two-graph receiver operating characteristic (TG-ROC): a Microsoft-Excel template for the selection of cut-off values in diagnostic tests J. Immunol. Methods 185 1 1995 145 146 10.1016/0022-1759(95)00078-O 7665897
18. Grothe M., Heinsen H., and Teipel S. Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease Neurobiol. Aging 34 4 2012 1210 1220
19. Grothe M., Heinsen H., and Teipel S.J. Atrophy of the cholinergic basal forebrain over the adult age range and in early stages of Alzheimer's disease Biol. Psychiatry 71 9 2012 805 813 10.1016/j.biopsych.2011.06.019 21816388
20. Grothe M., Zaborszky L., Atienza M., Gil-Neciga E., Rodriguez-Romero R., Teipel S.J., Amunts K., Suarez-Gonzalez A., and Cantero J.L. Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease Cereb. Cortex 20 7 2010 1685 1695 10.1093/cercor/bhp232 19889714
21. Grothe M.J., Ewers M., Krause B., Heinsen H., and Teipel S.J. Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects Alzheimers Dement. 10 2014 S344 S353 10.1016/j.jalz.2013.09.011 24418052
22. Haense C., Kalbe E., Herholz K., Hohmann C., Neumaier B., Krais R., and Heiss W.D. Cholinergic system function and cognition in mild cognitive impairment Neurobiol. Aging 33 5 2012 867 877 10.1016/j.neurobiolaging.2010.08.015 20961662
23. Hall A.M., Moore R.Y., Lopez O.L., Kuller L., and Becker J.T. Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease Alzheimers Dement. 4 4 2008 271 279 10.1016/j.jalz.2008.04.005 18631978
24. Herholz K., Weisenbach S., and Kalbe E. Deficits of the cholinergic system in early AD Neuropsychologia 46 6 2008 1642 1647 10.1016/j.neuropsychologia.2007.11.024 18201734
25. Kim M.J., Lee K.M., Son Y.D., Jeon H.A., Kim Y.B., and Cho Z.H. Increased basal forebrain metabolism in mild cognitive impairment: an evidence for brain reserve in incipient dementia J. Alzheimers Dis. 32 4 2012 927 938 10.3233/JAD-2012-120133 22903128
26. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergström M., Savitcheva I., Huang G.F., Estrada S., Ausén B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., and Långström B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B Ann. Neurol. 55 3 2004 306 319 10.1002/ana.20009 14991808
27. Knowles J.K., Rajadas J., Nguyen T.V., Yang T., LeMieux M.C., Vander Griend L., Ishikawa C., Massa S.M., Wyss-Coray T., and Longo F.M. The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo J. Neurosci. 29 34 2009 10627 10637 10.1523/JNEUROSCI.0620-09.2009 19710315
28. 11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis J. Alzheimers Dis. 31 2 2012 387 399 10.3233/JAD-2012-111748 22596267
29. Mesulam M. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn. Mem. 11 1 2004 43 49 10.1101/lm.69204
30. Mesulam M.M., Mufson E.J., Levey A.I., and Wainer B.H. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey J. Comp. Neurol. 214 2 1983 170 197 10.1002/cne.902140206 6841683
31. Mufson E.J. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction J. Chem. Neuroanat. 26 4 2003 233 242 10.1016/S0891-0618(03)00068-1 14729126
32. Muth K., Schönmeyer R., Matura S., Haenschel C., Schröder J., and Pantel J. Mild cognitive impairment in the elderly is associated with volume loss of the cholinergic basal forebrain region Biol. Psychiatry 67 6 2010 588 591 10.1016/j.biopsych.2009.02.026 19375072
33. Ramos-Rodriguez J.J., Pacheco-Herrero M., Thyssen D., Murillo-Carretero M.I., Berrocoso E., Spires-Jones T.L., Bacskai B.J., and Garcia-Alloza M. Rapid beta-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice J. Neuropathol. Exp. Neurol. 72 4 2013 272 285 10.1097/NEN.0b013e318288a8dd 23481704
34. Rowe C.C., Ellis K.A., Rimajova M., Bourgeat P., Pike K.E., Jones G., Fripp J., Tochon-Danguy H., Morandeau L., O'Keefe G., Price R., Raniga P., Robins P., Acosta O., Lenzo N., Szoeke C., Salvado O., Head R., Martins R., Masters C.L., Ames D., and Villemagne V.L. Amyloid imaging results from the Australian imaging, biomarkers and lifestyle (AIBL) study of aging Neurobiol. Aging 31 8 2010 1275 1283 10.1016/j.neurobiolaging.2010.04.007 20472326
35. Schliebs R., and Arendt T. The cholinergic system in aging and neuronal degeneration Behav. Brain Res. 221 2 2011 555 563 10.1016/j.bbr.2010.11.058 21145918
36. Sotthibundhu A., Sykes A.M., Fox B., Underwood C.K., Thangnipon W., and Coulson E.J. Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor J. Neurosci. 28 15 2008 3941 3946 10.1523/JNEUROSCI.0350-08.2008 18400893
37. Teipel S., Heinsen H., Amaro E. Jr., Grinberg L.T., Krause B., and Grothe M. Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease Neurobiol. Aging 35 3 2014 482 491 10.1016/j.neurobiolaging.2013.09.029 24176625
38. Villain N., Chételat G., Grassiot B., Bourgeat P., Jones G., Ellis K.A., Ames D., Martins R.N., Eustache F., Salvado O., Masters C.L., Rowe C.C., and Villemagne V.L. Regional dynamics of amyloid-beta deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study Brain 135 7 2012 2126 2139 10.1093/brain/aws125 22628162
39. Villemagne V.L., Pike K.E., Chételat G., Ellis K.A., Mulligan R.S., Bourgeat P., Ackermann U., Jones G., Szoeke C., Salvado O., Martins R., O'Keefe G., Mathis C.A., Klunk W.E., Ames D., Masters C.L., and Rowe C.C. Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease Ann. Neurol. 69 1 2011 181 192 10.1002/ana.22248 21280088
40. Zaborszky L., Hoemke L., Mohlberg H., Schleicher A., Amunts K., and Zilles K. Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain Neuroimage 42 3 2008 1127 1141 10.1016/j.neuroimage.2008.05.055 18585468